Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies. Founded by Wes Kaupinen in 2015, Palvella Therapeutics is backed by investors that include Adams Street Partners, Ligand Pharmaceuticals, Samsara BioCapital, BioAdvance, and Agent Capital and is headquartered in Wayne.